Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat vs HandiHaler small airway effects in COPD
2015-001615-13Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tiotropium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Imperial College London. Primary endpoint: Impulse oscillometry R5-R20. Started Jun 2015; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2015-001615-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001615-13.